Advanced Biomed Inc. (ADVB)
Q4-CY2026Q3-CY2026Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014
Balance Sheet Date2026-Jun-302026-Mar-312025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-31
Fiscal PeriodQ4-FY2026Q3-FY2026Q2-FY2026Q1-FY2026Q4-FY2025Q3-FY2025Q2-FY2025
Close Price of Common Stock6.82$6.57$4.75$4.33$0.32$0.44$0.70$3.92$
Market Cap of Common Stock9,426,147$9,073,703$6,565,132$93,593,000$7,011,360$9,536,748$15,126,360$
QoQ%3.88%38.21%(92.99%)1,234.88%(26.48%)(36.95%)
YoY%34.44%(4.86%)(56.60%)
Common Shares Outstanding1,652,1331,652,1331,382,13321,640,00021,640,0001,082,00021,640,00020,000,00020,000,00020,000,00020,000,00020,000,000
QoQ%19.54%(93.61%).00%1,900.00%(95.00%)8.20%.00%.00%.00%.00%
YoY%(92.37%)52.69%(93.61%)8.20%8.20%(94.59%)8.20%.00%
Price to Sales
Price to Earnings1.41x1.36x.98x17.72x1.60x--
Price to Book.77x.74x.53x10.16x.74x3.17x4.35x
Total Revenue
QoQ%
YoY%
TTM
TTM_QoQ%
TTM_YoY%
Gross Margin
QoQ
YoY
Operating Income
QoQ%
YoY%
TTM
TTM_QoQ%
TTM_YoY%
Operating Margin
QoQ
YoY
Net Income694,999$(488,942$)6,857,921$(386,901$)(701,611$)(1,383,874$)(907,904$)(265,580$)(809,386$)(1,056,231$)(145,345$)
QoQ%242.14%(107.13%)1,872.53%44.86%49.30%(52.43%)(241.86%)67.19%23.37%(626.71%)
YoY%199.06%64.67%855.36%(45.68%)13.32%(31.02%)(524.65%)
TTM6,677,077$5,280,467$4,385,535$(3,380,290$)(3,258,969$)(3,366,744$)(3,039,101$)(2,276,542$)
TTM_QoQ%26.45%20.41%229.74%(3.72%)3.20%(10.78%)(33.50%)
TTM_YoY%304.88%256.84%244.30%(48.48%)
Profit Margin
QoQ
YoY
Equity to Common Shareholders12,276,727$9,209,737$9,481,642$3,004,124$3,477,564$4,129,783$619,032$1,093,830$1,663,258$(497,797$)196,841$
QoQ3,066,990$(271,905$)6,477,518$(473,440$)(652,219$)3,510,751$(474,798$)(569,428$)2,161,055$(694,638$)
QoQ%33.30%(2.87%)215.62%(13.61%)(15.79%)567.14%(43.41%)(34.24%)434.12%(352.89%)
YoY8,799,163$5,079,954$8,862,610$1,910,294$1,814,306$4,627,580$422,191$
YoY%253.03%123.01%1,431.69%174.64%109.08%929.61%214.48%
Dividends Paid
Additional Paid-In Capital QoQ
Treasury Stock
QoQ
Goodwill
QoQ%
YoY%
Other Intangible Assets20,325$50,516$118,998$
QoQ(30,191$)
Amortization of Intangible Assets30,191$33,554$31,899$31,692$
Total Assets13,750,716$10,646,324$10,850,712$6,242,970$22,862,095$8,287,598$4,504,152$4,460,247$
QoQ3,104,392$(204,388$)4,607,742$(16,619,125$)14,574,497$3,783,446$
YoY(9,111,379$)2,358,726$6,346,560$18,401,848$
Total Liabilities1,473,989$1,436,587$1,369,070$3,238,846$19,384,531$4,157,815$3,885,120$2,796,989$
QoQ37,402$67,517$(1,869,776$)(16,145,685$)15,226,716$272,695$
YoY(17,910,542$)(2,721,228$)(2,516,050$)16,587,542$
Current Ratio9.33x7.38x8.56x1.92x1.16x1.88x.82x1.12x
Total Current Assets13,749,512$10,526,309$10,731,565$5,844,133$22,382,323$7,731,148$3,138,891$3,051,110$
QoQ3,223,203$(205,256$)4,887,432$(16,538,190$)14,651,175$4,592,257$
Total Current Liabilities1,473,989$1,425,684$1,253,574$3,044,952$19,238,880$4,113,343$3,828,794$2,732,460$
QoQ48,305$172,110$(1,791,378$)(16,193,928$)15,125,537$284,549$
Debt to Asset Ratio.11x.13x.13x.52x.85x.50x.86x.63x
Long Term Debt
QoQ
YoY
Capital Lease Obligations29,511$21,092$30,869$41,690$182,829$290,027$126,740$
Cash and Cash Equivalents
QoQ
YoY
Interest Expenses16,108$112$
Interest Income0$0$9,206$448$9,512$(24$)15,377$10$33,411$104$19,966$